373 related articles for article (PubMed ID: 16775092)
1. Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.
Belardinelli L; Shryock JC; Fraser H
Heart; 2006 Jul; 92 Suppl 4(Suppl 4):iv6-iv14. PubMed ID: 16775092
[TBL] [Abstract][Full Text] [Related]
2. A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine.
Maier LS
J Cardiovasc Pharmacol; 2009 Oct; 54(4):279-86. PubMed ID: 19333133
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sodium-dependent calcium overload to treat myocardial ischemia.
Conti CR
Clin Cardiol; 2006 Apr; 29(4):141-3. PubMed ID: 16649721
[TBL] [Abstract][Full Text] [Related]
4. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
[TBL] [Abstract][Full Text] [Related]
5. Late sodium current inhibition alone with ranolazine is sufficient to reduce ischemia- and cardiac glycoside-induced calcium overload and contractile dysfunction mediated by reverse-mode sodium/calcium exchange.
Soliman D; Wang L; Hamming KS; Yang W; Fatehi M; Carter CC; Clanachan AS; Light PE
J Pharmacol Exp Ther; 2012 Nov; 343(2):325-32. PubMed ID: 22879384
[TBL] [Abstract][Full Text] [Related]
6. Reducing the late sodium current improves cardiac function during sodium pump inhibition by ouabain.
Hoyer K; Song Y; Wang D; Phan D; Balschi J; Ingwall JS; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2011 May; 337(2):513-23. PubMed ID: 21325441
[TBL] [Abstract][Full Text] [Related]
7. New treatment options for late Na current, arrhythmias, and diastolic dysfunction.
Maier LS
Curr Heart Fail Rep; 2012 Sep; 9(3):183-91. PubMed ID: 22767404
[TBL] [Abstract][Full Text] [Related]
8. Late sodium current inhibition as a new cardioprotective approach.
Hale SL; Shryock JC; Belardinelli L; Sweeney M; Kloner RA
J Mol Cell Cardiol; 2008 Jun; 44(6):954-967. PubMed ID: 18462746
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the late sodium current slows t-tubule disruption during the progression of hypertensive heart disease in the rat.
Aistrup GL; Gupta DK; Kelly JE; O'Toole MJ; Nahhas A; Chirayil N; Misener S; Beussink L; Singh N; Ng J; Reddy M; Mongkolrattanothai T; El-Bizri N; Rajamani S; Shryock JC; Belardinelli L; Shah SJ; Wasserstrom JA
Am J Physiol Heart Circ Physiol; 2013 Oct; 305(7):H1068-79. PubMed ID: 23873796
[TBL] [Abstract][Full Text] [Related]
10. An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes.
Song Y; Shryock JC; Belardinelli L
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2031-9. PubMed ID: 18310511
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyocytes from postinfarction failing rat hearts have improved ischemia tolerance.
Sharikabad MN; Aronsen JM; Haugen E; Pedersen J; Møller AS; Mørk HK; Aass HC; Sejersted OM; Sjaastad I; Brørs O
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H787-95. PubMed ID: 19136604
[TBL] [Abstract][Full Text] [Related]
12. Ranolazine and late cardiac sodium current--a therapeutic target for angina, arrhythmia and more?
Makielski JC; Valdivia CR
Br J Pharmacol; 2006 May; 148(1):4-6. PubMed ID: 16520741
[TBL] [Abstract][Full Text] [Related]
13. Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current.
Undrovinas AI; Belardinelli L; Undrovinas NA; Sabbah HN
J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1(Suppl 1):S169-S177. PubMed ID: 16686675
[TBL] [Abstract][Full Text] [Related]
14. Nav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice.
Yao L; Fan P; Jiang Z; Viatchenko-Karpinski S; Wu Y; Kornyeyev D; Hirakawa R; Budas GR; Rajamani S; Shryock JC; Belardinelli L
Am J Physiol Cell Physiol; 2011 Sep; 301(3):C577-86. PubMed ID: 21677263
[TBL] [Abstract][Full Text] [Related]
15. Anti-anginal and anti-ischemic effects of late sodium current inhibition.
Wimmer NJ; Stone PH
Cardiovasc Drugs Ther; 2013 Feb; 27(1):69-77. PubMed ID: 23247666
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of late sodium current to reduce electrical and mechanical dysfunction of ischaemic myocardium.
Shryock JC; Belardinelli L
Br J Pharmacol; 2008 Mar; 153(6):1128-32. PubMed ID: 18071302
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of the new anti-ischemia drug ranolazine.
Hasenfuss G; Maier LS
Clin Res Cardiol; 2008 Apr; 97(4):222-6. PubMed ID: 18046526
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
Fredj S; Sampson KJ; Liu H; Kass RS
Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
[TBL] [Abstract][Full Text] [Related]
19. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
Doshi D; Morrow JP
Rev Cardiovasc Med; 2009; 10 Suppl 1():S46-52. PubMed ID: 19898288
[TBL] [Abstract][Full Text] [Related]
20. The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction.
Wu Y; Song Y; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2009 Aug; 330(2):550-7. PubMed ID: 19403851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
